Clinical TrialsSearch results
Number of results: 805
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- ONO-7475-04:A Phase1 study of ONO-7475 in combination with ONO-4538 and gemcitabine plus nab-paclitaxel (GnP), the standard of care, and ONO-7475 in combination with GnP in patients with pancreatic cancer
- metastatic pancreatic cancer
- Hirashima Yoshinori
- 2023-11-03
Recruiting
- ONO-4578-08:A study to investigate the efficacy and safety of ONO-4578 in combination with nivolumab and
chemotherapy compared with those of placebo in combination with nivolumab and chemotherapy
in chemotherapy-naive participants with HER2-negative unresectable advanced or recurrent gastric cancer (including esophagogastric junction cancer)
- Unresectable Advanced or Recurrent Gastric Cancer
- Hirashima Yoshinori
- 2023-10-12
Recruiting
- ONO-2017-02:An Open-Label Extension study of Cenobamate in Japanese Subjects with Partial Onset Seizures
- Partial Onset Seizures with epilepsy
- Osawa Masahiro
- 2022-07-08
Recruiting
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial
- Atherosclerotic Cardiovascular Disease
- Asato Keita
- 2023-01-31
Recruiting
- None
- depressive states
- Fujita Junichi
- 2023-10-31
Recruiting
- Non-inferiority study of GSK3511294 compared with mepolizumab or benralizumab in participants with severe asthma with an eosinophilic phenotype
- asthma
- Hirashima Aki
- 2021-03-11
Recruiting
- NeoNivo study
- MSI-H/dMMR locally advanced colorectal cancer
- Suwa Yusuke
- 2023-04-11
Recruiting
- Necitumumab and Gemcitabine combination therapy for advanced Biliary tract cancer with EGFR Amplification phase2 Trial
- biliary tract cancer
- Sugimori Makoto
- 2023-07-27
Recruiting
- Multicenter prospective observational study to identify plasm beta cell-specific peptides
- Type 1 diabetes
- Miyatsuka Takeshi
- 2022-06-04
Recruiting
- M201-A
- Symptomatic Paroxysmal atrial fibrillation
- Kumagai Yuji
- 2019-08-07